# Molina Healthcare, Inc.: Form 10-Q for the period ended Mar 31, 2024

- Company: [Molina Healthcare, Inc.](/companies/moh.md) (CIK 1179929)
- Form: 10-Q
- Filed: 2024-04-25
- Accepted by EDGAR: Apr 25, 2024, 09:40 ET
- Period: 2024-03-31
- Accession: 0001179929-24-000089
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1179929/000117992924000089/moh-20240331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1179929/000117992924000089/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2024-01-01 to 2024-03-31 | $9.93bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2024-01-01 to 2024-03-31 | $8.41bn | us-gaap:CostOfGoodsAndServicesSold |
| Operating income | 3 months, 2024-01-01 to 2024-03-31 | $426.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2024-01-01 to 2024-03-31 | $27.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2024-01-01 to 2024-03-31 | $98.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2024-01-01 to 2024-03-31 | $301.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2024-01-01 to 2024-03-31 | $5.17 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2024-01-01 to 2024-03-31 | $5.21 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2024-01-01 to 2024-03-31 | 58,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2024-01-01 to 2024-03-31 | $214.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2024-01-01 to 2024-03-31 | $27.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2024-03-31 | $4.51bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-03-31 | $12.67bn | us-gaap:AssetsCurrent |
| Total assets | at 2024-03-31 | $15.51bn | us-gaap:Assets |
| Current liabilities | at 2024-03-31 | $8.51bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-03-31 | $11.02bn | us-gaap:Liabilities |
| Long-term debt | at 2024-03-31 | $2.18bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2024-03-31 | $4.49bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1179929/000117992924000089/moh-20240331.htm

Filed Apr 25, 2024.
Source: SEC EDGAR, the filing index for accession 0001179929-24-000089. Last ingested by Listed: Nov 11, 2026, 00:18 ET. No prices; not investment advice.
